PDCD1 and cancer: ,18 Currently, immunotherapy is an essential treatment for many cancer types, and recent preclinical and clinical evidence19, 20, 21 has shown promise in treating cancer by utilizing checkpoint inhibitors, including anti (α)-PD1, αPD-L1, and αCTLA4 antibodies, and vaccines.